WIRE — The maker of Wegovy and Ozempic, Novo Nordisk, has launched legal action accusing its arch-rival Eli Lilly of false advertising in suggesting its weight-loss drugs perform better.
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.